Clinical Trial Update: Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD [NA]

View source ↗

Summary

A recruiting Alzheimer's disease trial aims to validate resilience metrics and risk factors in the BioCogBank-AD cohort for precision medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alzheimer Disease | NA | Status: RECRUITING